Lex

AstraZeneca's Christmas shopping

UK drugmaker AstraZeneca is in talks to acquire cancer drug developer Acerta Pharma, possibly for more than $5bn. Lex's Oliver Ralph and Jonathan Eley discuss the challenges AstraZeneca has faced in recent years and why the potential takeover is important.